SCHEMBL543080

SCHEMBL543080

CC1=NC(Cc2ccccc2)(Cc2ccccc2)C(=O)N1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 3/20 0.40
MMP2 P08253 3/20 0.40
MMP13 P45452 3/20 0.40
MMP8 P22894 2/20 0.40
ADAM17 P78536 1/20 0.39
ELANE P08246 2/20 0.38
ALDH1A1 P00352 3/20 0.37
CYP3A4 P08684 2/20 0.37
POLB P06746 1/20 0.37
KDM4E B2RXH2 1/20 0.37
CYP1A2 P05177 1/20 0.37
MAPT P10636 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
CACNA1B Q00975 1/20 0.37
APBA1 Q02410 1/20 0.37
BACE1 P56817 1/20 0.37
ATM Q13315 1/20 0.36
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13495126 0.68 MMP9 (0.43) MMP9MMP2MMP13MMP8ADAM17
SCHEMBL29195204 0.66 ELANE (0.46) MMP9MMP2MMP13MMP8ADAM17
SCHEMBL5448618 0.65 MMP9 (0.64) MMP9MMP2MMP13MMP8ADAM17
SCHEMBL16865428 0.64 MMP9 (0.56) MMP9MMP2MMP13MMP8ADAM17
SCHEMBL1743250 0.63 ELANE (0.44) ELANEALDH1A1CYP3A4CYP1A2CYP2C9
SCHEMBL7272506 0.63 ELANE (0.40) MMP9MMP2MMP13MMP8ELANE
SCHEMBL7219255 0.63 ELANE (0.40) MMP9MMP2MMP13MMP8ELANE
SCHEMBL11256566 0.62 ELANE (0.42) MMP9MMP2MMP13MMP8ADAM17
SCHEMBL7097777 0.62 ALDH1A1 (0.60) MMP9MMP2MMP13MMP8ADAM17
SCHEMBL15972776 0.62 ALDH1A1 (0.60) MMP9MMP2MMP13MMP8ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012094615-A2 USE OF CAV3.1 SELECTIVE T-TYPE CALCIUM CHANNEL ANTAGONISTS ZENYAKU KOGYO KABUSHIKIKAISHA (JP) 2012-07-12 WO disclosed
EP-2429522-A2 METHOD OF DECREASING UBIQUITYLATED PROTEIN LEVELS The Regents of the University of California Office of Technology Transfer (US) 2012-03-21 EP disclosed
EP-2419100-A2 METHOD OF DECREASING PRO-ADAM10 SECRETASE AND/OR BETA SECRETASE LEVELS Green, Kim Nicholas (US) 2012-02-22 EP disclosed
EP-2413929-A2 METHOD OF TREATING COGNITIVE IMPAIRMENT Zenyaku Kogyo Co., Ltd (JP) 2012-02-08 EP disclosed
EP-2361088-A2 METHOD OF INDUCING CLEAVAGE OF AMYLOID PRECURSOR PROTEIN TO FORM A NOVEL FRAGMENT The Regents Of The University Of California (US) 2011-08-31 EP disclosed
WO-2010132390-A2 METHOD OF DECREASING UBIQUITYLATED PROTEIN LEVELS GREEN KIM NICHOLAS (US) 2010-11-18 WO disclosed
WO-2010120872-A2 METHOD OF DECREASING PRO-ADAM10 SECRETASE AND/OR BETA SECRETASE LEVELS GREEN KIM NICHOLAS (US) 2010-10-21 WO disclosed
WO-2010115078-A2 METHOD OF TREATING COGNITIVE IMPAIRMENT WEBER ECKARD (US) 2010-10-07 WO disclosed
WO-2010077852-A2 METHOD OF INDUCING CLEAVAGE OF AMYLOID PRECURSOR PROTEIN TO FORM A NOVEL FRAGMENT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-07-08 WO disclosed
EP-2077835-A2 AN ALZHEIMER'S DISEASE PROGRESSION INHIBITOR CONTAINING HETEROCYCLIC COMPOUND ZENYAKU KOGYO KABUSHIKI KAISHA (JP) 2009-07-15 EP disclosed
EP-2077836-A2 ANTIDEPRESSANT, NEUROPROTECTANT, AMYLOID BETA DEPOSITION INHIBITOR OR AGE RETARDANT CONTAINING HETEROCYCLIC COMPOUND ZENYAKU KOGYO KABUSHIKI KAISHA (JP) 2009-07-15 EP disclosed
WO-2008047951-A2 AN ALZHEIMER' S DISEASE PROGRESSION INHIBITOR CONTAINING HETEROCYCLIC COMPOUND ZENYAKU KOGYO KABUSHIKIKAISHA (JP) 2008-04-24 WO disclosed
WO-2008047952-A2 ANTIDEPRESSANT, NEUROPROTECTANT, AMYLOID BETA DEPOSITION INHIBITOR OR AGE RETARDANT CONTAINING HETEROCYCLIC COMPOUND ZENYAKU KOGYO KABUSHIKIKAISHA (JP) 2008-04-24 WO disclosed